Transgenic farm animals have not gained importance as sources of pharmaceuticals because

there’s another way to retroviruses is to make more strong screening methods to tell if the transgene is functioning properly in the embryo before it is implanted in the uterus. The approach leads to fewer problems with development, but it has raised concerns about the possibility.